NeuroLaunch
3
199K
2
0.38
0.33
- Stages of investment
- Areas of investment
Summary
In 2014 was created NeuroLaunch, which is appeared as VC. The fund was located in North America if to be more exact in United States. The main department of described VC is located in the Atlanta.
The current fund was established by Christopher Klaus, Jim Schwoebel.
The usual cause for the fund is to invest in rounds with 2 partakers. Despite the NeuroLaunch, startups are often financed by Sky Ventures Group, Capital Cell. The meaningful sponsors for the fund in investment in the same round are Walter Gilbert. In the next rounds fund is usually obtained by Open Data Incubator for Europe (ODINE), EASME - EU Executive Agency for SMEs.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Among the most successful fund investment fields, there are Software, Health Care. Among the various public portfolio startups of the fund, we may underline QMENTA Besides, a startup needs to be aged 2-3 years to get the investment from the fund.
Deals in the range of 100 thousands - 1 million dollars are the general things for fund. The important activity for fund was in 2015. The fund is generally included in less than 2 deals every year.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 0
- Rounds per year
- 0.38
- Follow on index
- 0.33
- Investments by industry
- Information Technology (3)
- Software (3)
- Pharmaceutical (3)
- Health Care (3)
- Clinical Trials (2) Show 5 more
- Investments by region
-
- United States (3)
- Peak activity year
- 2015
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 8
- Avg. valuation at time of investment
- 3M
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| QMENTA | 14 Dec 2015 | Software, Information Technology, Artificial Intelligence, Health Care, Medical Device, Medical, Neuroscience, Pharmaceutical, Image Recognition, Clinical Trials | Seed | 478K | United States, Massachusetts, Boston |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.